Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Corkill

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1993
Intramuscular methylprednisolone is superior to pulse oral methylprednisolone during the induction phase of chrysotherapyE H Choy, G H Kingsley, M M Corkill, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1990
Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trialM M Corkill, B W Kirkham, I C Chikanza, et al.
The Journal of Rheumatology|December 22, 1999
Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followupW J Taylor, C N Rajapakse, K A Harris, et al.
The Journal of Rheumatology|October 1, 1991
Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1M M Corkill, B W Kirkham, D O Haskard, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1993
Intramuscular methylprednisolone is superior to pulse oral methylprednisolone during the induction phase of chrysotherapyE H Choy, G H Kingsley, M M Corkill, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1990
Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trialM M Corkill, B W Kirkham, I C Chikanza, et al.
The Journal of Rheumatology|December 22, 1999
Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followupW J Taylor, C N Rajapakse, K A Harris, et al.
The Journal of Rheumatology|October 1, 1991
Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1M M Corkill, B W Kirkham, D O Haskard, et al.
Pageof 2